Home > PJ (Current issue) > Meetings and Conferences | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7269 p473
4 October 2003

This article
Reprint
Photocopy

   

PDF* 70K

Meetings & Conferences

See Reports

UniChem convention 2003

UniChem’s 2003 convention was held in Dubai from 26 September to 3 October. The convention was attended by more than 300 participants and the theme was “Perception is reality”. This week’s coverage examines how pharmacists and general practitioners can work more closely together. Dawn Connelly (on the staff of The Journal) reports

Pharmacists must work in partnership with other health care professionals

Chris Town: pharmacists are needed on PCT committees

Community pharmacists must create and improve relationships with primary care trusts, said Chris Town, chief executive, Greater Peterborough Primary Care Partnership (an alliance of two primary care trusts and social services). “If you haven’t already got a pharmacist on the professional executive committee of the PCT then I urge you to do so,” he said.

Mr Town explained that PCTs will hold the new general practitioner contract from 1 April 2004 and that, in his opinion, the new community pharmacy contract will be implemented by PCTs from 1 April 2005.

Mr Town chairs the tripartite meetings between the NHS Confederation (representing PCTs), the Department of Health and the Pharmaceutical Services Negotiating Committee on the new pharmacy contract. He said that all parties are anxious to ensure that, when the new contract rolls out, there are people with adequate skills within each PCT. “To me, it is essential that, as part of the team, there is a qualified community pharmacist who understands the rules,” he said.

Mr Town went on to say that he believes that both of the new contracts offer opportunities for pharmacists, technicians and assistants. They could take on new roles, for example, in supplementary and independent prescribing, in improving concordance and in medicines management.

So how can all this be achieved? Mr Town recognises that these opportunities will require a significant time commitment from community pharmacists if the benefits are to be delivered. He believes that this can be tackled through changes in skill mix and improvements in information technology. “First, I think we do need urgently to change the supervision rules and allow an expanded role for technicians,” he suggested. “Second, we need to invest in information technology to carry out the functions I described.” Pharmacists need to have real time access to patient records, he added.

It is also essential that local pharmaceutical committees work together with the profession and PCTs in promoting these exciting opportunities and challenges, he concluded.


New contract for GP will allow partnerships with pharmacists

Co-operative working between pharmacists and general practitioners has benefits in sharing of workload, demand management, the extension of prescribing roles and in medicines management, said Dr John Chisholm, chairman of the General Practitioners’ Committee, British Medical Association.

The new GP contract will allow mixed alliances, with pharmacists, managers and nurses increasingly entering partnerships with doctors, said Dr Chisholm. “At the heart of the contract is giving practices great flexibility and autonomy in how they deliver services, allowing them their own choices as to how they organise the care of their patients, while judging them on the quality and outcomes of the care they provide,” he explained.

The new pharmacy contract also needs to reflect the expectations of patients and facilitate enhanced roles for pharmacists and GPs, he told participants.

Dr Chisholm commented that it is perhaps not surprising that many aspects of the GP and pharmacy contracts are similar. Features common to both contracts include a wish to improve the range and quality of services, an emphasis on quality, not quantity, categorisation of services, an element of choice in commissioning services, changes in funding flow, better use of skill mix, undertaking of new roles, and development of the two contracts in parallel.

Dr Chisholm concluded by saying that although he is an enthusiast for interprofessional working and he believes that many GPs will welcome pharmacists taking on extended roles, there is still work to be done in convincing some doctors, who may perceive these changes as an undesirable threat.

During a question and answer session, Kirit Patel, chairman of the Day Lewis group, asked whether the movement being seen towards doctors owning pharmacies within surgeries would drive a wedge between the two professions just when they are trying to work together.

Dr Chisholm commented that from a patient’s perspective there are advantages in co-location and that close working between doctors and pharmacists is going to result in better medicines management. “I don’t see that there is a fundamental conflict of interest that cannot be resolved,” he said.

John D’Arcy, chief executive of the National Pharmaceutical Association, disagreed: “There is a conflict, but the question is whether it can be managed.”

He added that this was an issue that the NPA took up in its response to theOffice of Fair Trading report. “It is important that we make sure that it doesn’t become the agenda and get in the way of the real agenda, which is working together, ” he said.


UniChem has no plans for patient deliveries

During the question and answer session, John Nuttall, a pharmacist from Nantwich, Cheshire, asked if wholesalers would move into making supplies direct to patients.

Geoff Cooper, deputy chief executive, Alliance UniChem, responded: “We could, but we don’t think we would make any money at all.”

However, he does think that there will be a role for some wholesalers in helping pharmacists, for example, with mail order delivery of pharmaceuticals. Any deliveries would be made to patients on behalf of the pharmacies the patients visited, not on behalf of wholesalers.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal